- Home
- AMBI vs FENC Comparison
AMBI vs FENC Comparison
Compare AMBI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBI
- FENC
- Stock Information
- Founded
- AMBI 1995
- FENC 1996
- Country
- AMBI Brazil
- FENC United States
- Employees
- AMBI N/A
- FENC N/A
- Industry
- AMBI Environmental Services
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMBI Industrials
- FENC Health Care
- Exchange
- AMBI Nasdaq
- FENC Nasdaq
- Market Cap
- AMBI 265.0M
- FENC 225.4M
- IPO Year
- AMBI N/A
- FENC 2001
- Fundamental
- Price
- AMBI N/A
- FENC $9.24
- Analyst Decision
- AMBI
- FENC Strong Buy
- Analyst Count
- AMBI 0
- FENC 2
- Target Price
- AMBI N/A
- FENC $13.50
- AVG Volume (30 Days)
- AMBI 742.3K
- FENC 93.7K
- Earning Date
- AMBI 08-12-2014
- FENC 11-06-2025
- Dividend Yield
- AMBI N/A
- FENC N/A
- EPS Growth
- AMBI N/A
- FENC N/A
- EPS
- AMBI N/A
- FENC N/A
- Revenue
- AMBI $525,221,427.00
- FENC $33,302,000.00
- Revenue This Year
- AMBI N/A
- FENC $0.18
- Revenue Next Year
- AMBI N/A
- FENC $52.59
- P/E Ratio
- AMBI N/A
- FENC N/A
- Revenue Growth
- AMBI 25.42
- FENC N/A
- 52 Week Low
- AMBI $0.72
- FENC $3.96
- 52 Week High
- AMBI $8.20
- FENC $9.92
- Technical
- Relative Strength Index (RSI)
- AMBI 14.89
- FENC N/A
- Support Level
- AMBI $1.06
- FENC N/A
- Resistance Level
- AMBI $1.38
- FENC N/A
- Average True Range (ATR)
- AMBI 0.41
- FENC 0.00
- MACD
- AMBI -0.37
- FENC 0.00
- Stochastic Oscillator
- AMBI 2.28
- FENC 0.00
About AMBI Ambipar Emergency Response
Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.